These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12459001)
1. Summaries for patients. Screening for prostate cancer: a recommendation from the U.S. Preventive Services Task Force. Ann Intern Med; 2002 Dec; 137(11):I48. PubMed ID: 12459001 [No Abstract] [Full Text] [Related]
2. Summaries for patients. Screening for prostate cancer with prostate-specific antigen testing: U.S. Preventive Services Task Force recommendations. Ann Intern Med; 2008 Aug; 149(3):I37. PubMed ID: 18678840 [No Abstract] [Full Text] [Related]
3. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. U.S. Preventive Services Task Force Ann Intern Med; 2008 Aug; 149(3):185-91. PubMed ID: 18678845 [TBL] [Abstract][Full Text] [Related]
4. Screening for prostate cancer: recommendation and rationale. U.S. Preventive Services Task Force Ann Intern Med; 2002 Dec; 137(11):915-6. PubMed ID: 12458992 [No Abstract] [Full Text] [Related]
5. Summaries for patients. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med; 2012 Jul; 157(2):I-44. PubMed ID: 22801691 [No Abstract] [Full Text] [Related]
6. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Moyer VA; Ann Intern Med; 2012 Jul; 157(2):120-34. PubMed ID: 22801674 [TBL] [Abstract][Full Text] [Related]
7. What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation. Catalona WJ; D'Amico AV; Fitzgibbons WF; Kosoko-Lasaki O; Leslie SW; Lynch HT; Moul JW; Rendell MS; Walsh PC Ann Intern Med; 2012 Jul; 157(2):137-8. PubMed ID: 22801676 [No Abstract] [Full Text] [Related]
8. Screening for prostate cancer: recommendations and rationale. Berg AO; Am J Nurs; 2003 Mar; 103(3):107-10; discussion 111. PubMed ID: 12626949 [No Abstract] [Full Text] [Related]
9. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Harris R; Lohr KN Ann Intern Med; 2002 Dec; 137(11):917-29. PubMed ID: 12458993 [TBL] [Abstract][Full Text] [Related]
10. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Lin K; Lipsitz R; Miller T; Janakiraman S; Ann Intern Med; 2008 Aug; 149(3):192-9. PubMed ID: 18678846 [TBL] [Abstract][Full Text] [Related]
11. Screening for prostate cancer: commentary on the recommendations of the Canadian Task Force on the Periodic Health Examination. The U.S. Preventive Services Task Force. Am J Prev Med; 1994; 10(4):187-93. PubMed ID: 7528518 [No Abstract] [Full Text] [Related]
12. Prostate-specific antigen testing: men's responses to 2012 recommendation against screening. Squiers LB; Bann CM; Dolina SE; Tzeng J; McCormack L; Kamerow D Am J Prev Med; 2013 Aug; 45(2):182-9. PubMed ID: 23867025 [TBL] [Abstract][Full Text] [Related]
13. Trends in Prostate-Specific Antigen Screening and Prostate Cancer Interventions 3 Years After the U.S. Preventive Services Task Force Recommendation. Ong MS; Mandl KD Ann Intern Med; 2017 Mar; 166(6):451-452. PubMed ID: 28320011 [No Abstract] [Full Text] [Related]
14. Screening for prostate cancer. American College of Physicians. Ann Intern Med; 1997 Mar; 126(6):480-4. PubMed ID: 9072936 [No Abstract] [Full Text] [Related]
15. Re: National Prostate Cancer Screening Rates after the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening. Taneja SS J Urol; 2016 Feb; 195(2):350-1. PubMed ID: 26852972 [No Abstract] [Full Text] [Related]
16. Words of wisdom: Re: Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Albertsen PC Eur Urol; 2013 Sep; 64(3):512. PubMed ID: 23915461 [No Abstract] [Full Text] [Related]
17. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation. Cohn JA; Wang CE; Lakeman JC; Silverstein JC; Brendler CB; Novakovic KR; McGuire MS; Helfand BT Urol Oncol; 2014 Jan; 32(1):41.e23-30. PubMed ID: 23911680 [TBL] [Abstract][Full Text] [Related]
18. The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--counterpoint. Catalona WJ Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):395-7. PubMed ID: 22315363 [No Abstract] [Full Text] [Related]
19. Grading the new US Preventive Services Task Force prostate cancer screening recommendation. Volk RJ; Wolf AM JAMA; 2011 Dec; 306(24):2715-6. PubMed ID: 22203540 [No Abstract] [Full Text] [Related]
20. Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening. Schröder FH N Engl J Med; 2011 Nov; 365(21):1953-5. PubMed ID: 22029756 [No Abstract] [Full Text] [Related] [Next] [New Search]